Pilot study on the effects of oral immuno-nutrition on the quality of life in patients receiving palliative treatment for oesophageal and proximal gastric cancer.
| ISRCTN | ISRCTN94245249 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN94245249 |
| Secondary identifying numbers | N0055143763 |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 05/03/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Martin White
Scientific
Scientific
North Cumbria Acute Hospitals NHS Trust
Cumberland Infirmary
Carlisle
CA2 7HY
United Kingdom
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Quality of life |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | Pilot study on the effects of oral immuno-nutrition on the quality of life in patients receiving palliative treatment for oesophageal and proximal gastric cancer. |
| Study objectives | Does EPA supplementation affect patients' quality of life and survival with known esophageal and proximal gastric cancer who are receiving non-curative treatments? |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Cancer: Gastrointestinal |
| Intervention | Patients, after obtaining informed consent, are randomly assigned one of the nutritional supplements, both of similar calorific value but one contains EPA. |
| Intervention type | Other |
| Primary outcome measure | Measurements of QoL, weight etc. are made at monthly interval, follow-up until death. |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/06/2002 |
| Completion date | 30/06/2004 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | Patients with histologically diagnosed oesophageal or proximal gastric cancer that are not receiving curative treatment. |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/06/2002 |
| Date of final enrolment | 30/06/2004 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
North Cumbria Acute Hospitals NHS Trust
Carlisle
CA2 7HY
United Kingdom
CA2 7HY
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Phone | +44 (0)20 7307 2622 |
|---|---|
| dhmail@doh.gsi.org.uk | |
| Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
North Cumbria Acute Hospitals NHS Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Editorial Notes
05/03/2020: No publications found. All search options exhausted.
